Gene · 239
Papers2,360
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,360
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Decoding the Ferroptosis-Related Gene Signatures and Immune Infiltration Patterns in Ovarian Cancer: Bioinformatic Prediction Integrated with Experimental Validation. | J Inflamm Res | 2024 | 39654865 | PubTator, text mining | PubMed |
| Revealing the core active pharmaceutical ingredients and targets of Jie-gu capsules for fracture treatment through network pharmacology and mendelian randomization. | Medicine (Baltimore) | 2024 | 39654220 | PubTator, text mining | PubMed |
| Structural and Functional Biology of Mammalian ALOX Isoforms with Particular Emphasis on Enzyme Dimerization and Their Allosteric Properties. | Int J Mol Sci | 2024 | 39596127 | PubTator, text mining | PubMed |
| Baicalein blocked gastric cancer cell proliferation and invasion through modulated platelet type 12-lipoxygenase. | Iran J Basic Med Sci | 2024 | 39539438 | PubTator, text mining | PubMed |
| 12-Lipoxygenase inhibition delays onset of autoimmune diabetes in human gene replacement mice. | JCI Insight | 2024 | 39531315 | PubTator, text mining | PubMed |
| Menaquinone-4 Alleviates Sepsis-Associated Acute Lung Injury via Activating SIRT3-p53/SLC7A11 Pathway. | J Inflamm Res | 2024 | 39469061 | PubTator, text mining | PubMed |
| Upregulation of ALOX12-12-HETE pathway impairs AMPK-dependent modulation of vascular metabolism in ApoE/LDLR-/- mice. | Pharmacol Res | 2024 | 39448044 | PubTator, text mining | PubMed |
| Palmitic acid inhibits macrophage-mediated chemotherapy resistance in multiple myeloma via ALOX12 signaling. | Int Immunopharmacol | 2024 | 39378653 | PubTator, text mining | PubMed |
| Genetic effects on the skin methylome in healthy older twins. | Am J Hum Genet | 2024 | 39137780 | PubTator, text mining | PubMed |
| 12-Lipoxygenase inhibition delays onset of autoimmune diabetes in human gene replacement mice. | bioRxiv | 2024 | 39091839 | PubTator, text mining | PubMed |
| Induction of ferroptosis by brucine suppresses gastric cancer progression through the p53-mediated SLCA711/ALOX12 axis. | Heliyon | 2024 | 39050447 | PubTator, text mining | PubMed |
| A precise microdissection strategy enabled spatial heterogeneity analysis on the targeted region of formalin-fixed paraffin-embedded tissues. | Talanta | 2024 | 38963978 | PubTator, text mining | PubMed |
| The involvement of IRP2-induced ferroptosis through the p53-SLC7A11-ALOX12 pathway in Parkinson's disease. | Free Radic Biol Med | 2024 | 38936518 | PubTator, text mining | PubMed |
| Immune cell related signature predicts prognosis in esophageal squamous cell carcinoma based on single-cell and bulk-RNA sequencing. | Front Oncol | 2024 | 38903709 | PubTator, text mining | PubMed |
| Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistance. | BMC Med Genomics | 2024 | 38902747 | PubTator, text mining | PubMed |
| Baicalein alleviates cisplatin-induced acute kidney injury by inhibiting ALOX12-dependent ferroptosis. | Phytomedicine | 2024 | 38805781 | PubTator, text mining | PubMed |
| Metabolomic and biochemical changes in the plasma and liver of toxic milk mice model of Wilson disease. | J Pharm Biomed Anal | 2024 | 38795427 | PubTator, text mining | PubMed |
| Luteolin attenuates CCl4-induced hepatic injury by inhibiting ferroptosis via SLC7A11. | BMC Complement Med Ther | 2024 | 38755566 | PubTator, text mining | PubMed |
| Enhanced ALOX12 Gene Expression Predicts Therapeutic Susceptibility to 5-Azacytidine in Patients with Myelodysplastic Syndromes. | Int J Mol Sci | 2024 | 38731802 | PubTator, text mining | PubMed |
| SBFI26 induces triple-negative breast cancer cells ferroptosis via lipid peroxidation. | J Cell Mol Med | 2024 | 38516826 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/239/papers?page=5